KR920700653A - Hiv 활성을 저해하는데 공력작용을 하는 뉴클레오시드 유도체 복합물. - Google Patents

Hiv 활성을 저해하는데 공력작용을 하는 뉴클레오시드 유도체 복합물.

Info

Publication number
KR920700653A
KR920700653A KR1019910701134A KR910701134A KR920700653A KR 920700653 A KR920700653 A KR 920700653A KR 1019910701134 A KR1019910701134 A KR 1019910701134A KR 910701134 A KR910701134 A KR 910701134A KR 920700653 A KR920700653 A KR 920700653A
Authority
KR
South Korea
Prior art keywords
dideoxy
hiv
derivative
fluoroinosine
beta
Prior art date
Application number
KR1019910701134A
Other languages
English (en)
Korean (ko)
Inventor
브랜코반 베라
제이 화이트 리차드
Original Assignee
원본미기재
온코겐 리미티드 파트너쉽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 온코겐 리미티드 파트너쉽 filed Critical 원본미기재
Publication of KR920700653A publication Critical patent/KR920700653A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019910701134A 1989-03-17 1990-03-16 Hiv 활성을 저해하는데 공력작용을 하는 뉴클레오시드 유도체 복합물. KR920700653A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32493489A 1989-03-17 1989-03-17
US324934 1989-03-17
US40190889A 1989-09-01 1989-09-01
US401908 1989-09-01
PCT/US1990/001424 WO1990011081A1 (en) 1989-03-17 1990-03-16 Inhibition of hiv using synergistic combinations of nucleoside derivatives

Publications (1)

Publication Number Publication Date
KR920700653A true KR920700653A (ko) 1992-08-10

Family

ID=26984692

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910701134A KR920700653A (ko) 1989-03-17 1990-03-16 Hiv 활성을 저해하는데 공력작용을 하는 뉴클레오시드 유도체 복합물.

Country Status (19)

Country Link
EP (1) EP0464137A4 (xx)
JP (1) JPH04504850A (xx)
KR (1) KR920700653A (xx)
CN (1) CN1045791A (xx)
AU (1) AU5351490A (xx)
CA (1) CA2050473A1 (xx)
DD (1) DD301787A9 (xx)
FI (1) FI914367A0 (xx)
GR (1) GR1000618B (xx)
HU (1) HU208254B (xx)
IL (1) IL93783A0 (xx)
NO (1) NO913659L (xx)
NZ (1) NZ232912A (xx)
OA (1) OA09555A (xx)
PL (1) PL284343A1 (xx)
PT (1) PT93449A (xx)
WO (1) WO1990011081A1 (xx)
YU (1) YU53790A (xx)
ZW (1) ZW3290A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0513917T4 (da) * 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger
CA2335617C (en) * 1998-06-24 2009-12-15 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
AU2002255707A1 (en) 2001-03-15 2002-10-03 Trustees Of Boston College, The Selective anti-viral nucleoside chain terminators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds
NZ226672A (en) * 1987-10-30 1991-07-26 Hoffmann La Roche 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Also Published As

Publication number Publication date
OA09555A (en) 1993-01-31
HUT57988A (en) 1992-01-28
PL284343A1 (en) 1991-06-03
GR1000618B (el) 1992-08-31
NO913659D0 (no) 1991-09-17
EP0464137A1 (en) 1992-01-08
ZW3290A1 (en) 1990-11-07
JPH04504850A (ja) 1992-08-27
CN1045791A (zh) 1990-10-03
CA2050473A1 (en) 1990-09-18
GR900100189A (en) 1990-07-31
YU53790A (sh) 1993-05-28
NO913659L (no) 1991-10-18
FI914367A0 (fi) 1991-09-17
HU208254B (en) 1993-09-28
PT93449A (pt) 1990-11-07
DD301787A9 (de) 1994-01-13
NZ232912A (en) 1992-06-25
AU5351490A (en) 1990-10-22
EP0464137A4 (en) 1992-01-15
IL93783A0 (en) 1990-12-23
WO1990011081A1 (en) 1990-10-04
HU902898D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
WO1994008585A8 (en) Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
KR900700094A (ko) 지방산과 모노글리세라이드의 항비루스 및 항세균 활성
KR880010777A (ko) 바이러스 억제제와 결합한 dsRNA로 인간의 바이러스 감염을 치료하는 방법
MY102693A (en) Antiviral nucleosides
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
MY104069A (en) Therapeutic nucleosides
KR890015742A (ko) 이병치료용 국소 제제
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
CA2067381A1 (en) Treatment of hiv infections and compounds useful therein
NL960024I1 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus gesmette patiënten.
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
BR9910071A (pt) Composição farmacêutica, processos para aumentar e manter a homogeneidade de uma composição farmacêutica e para tratar, reverter, reduzir ou inibir infecções retrovirais, uso de abacavir, lamivudina, zidovudina ou de um derivado farmaceuticamente aceitável dos mesmos, e de um agente de deslizamento farmaceuticamente aceitável, artigo de manufatura, e, processo para a preparação de uma composição farmacêutica
KR950701820A (ko) 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders)
DE69729958D1 (de) Verbindungen mit antiviraler aktivität
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
KR900700110A (ko) 선암 치료용 전사효소 저해제
KR920700653A (ko) Hiv 활성을 저해하는데 공력작용을 하는 뉴클레오시드 유도체 복합물.
KR900009083A (ko) 2', 3'-디데옥시푸린 뉴클레오사이드/푸린 뉴클레오 사이드 포스포릴라제 억제제 배합 치료법 및 조성물
EP0311107A3 (en) Anti-hiv active 3'-fluoro-purine-2',3'-dideoxyribosides
DK178188D0 (da) Antivirusmiddel
ATE79034T1 (de) Behandlung von viruskrankheiten.
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
KR890006665A (ko) 항-hiv 활성, 3'-아지도-2,6-디아미노푸린-2',3'-디데옥시리보사이드
KR880005920A (ko) 인체의 백혈구 인터페론 조성물과 피부 치료법
KR890009868A (ko) 1-메틸-β-옥소-α-(페닐카바모일)-2- 피롤프로피오니트릴의 트로메트아민염

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid